Pharmaceutical intermediates

Sparsentan Intermediates

6 pharmaceutical intermediates for Sparsentan. Indication: Glomerulosclerosis, Focal Segmental;Glomerulonephritis, IGA.

About Sparsentan

6 intermediates currently listed for Sparsentan. Request specifications, documentation or a quotation for any item below.

Sparsentan intermediates
Product Name	CAS No.	Molecular Formula	Physical Properties
(2-(N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)sulfamoyl)phenyl)boronic acid	415697-58-4	/	/
N-(4,5-dimethylisoxazol-3-yl)-N-(methoxymethyl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide	415697-56-2	/	/
4-bromo-3-(ethoxymethyl)benzaldehyde	837408-71-6	/	/
4-bromo-3-ethoxymethyl-benzoic acid ethyl ester	948349-66-4	/	/
N-(4,5-Dimethyl-3-isoxazolyl)-2'-(ethoxymethyl)-4'-formyl-N-(methoxymethyl)[1,1'-biphenyl]-2-sulfonamide	1026913-68-7	/	/
N-(4,5-dimethylisoxazol-3-yl)-2'-(ethoxymethyl)-4'-(hydroxymethyl)-N-(methoxymethyl)-[1,1'-biphenyl]-2-sulfonamide	1098924-76-5	/	/

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态